Acorah Software Products - Accounts Production 16.5.460 false true true 31 December 2023 1 January 2023 false 22 September 2025 true 1 January 2024 31 December 2024 31 December 2024 03995362 Mr Amarbir Johal Mr Amarbir Johal true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 03995362 2023-12-31 03995362 2024-12-31 03995362 2024-01-01 2024-12-31 03995362 frs-core:CurrentFinancialInstruments 2024-12-31 03995362 frs-core:FurnitureFittings 2024-12-31 03995362 frs-core:FurnitureFittings 2024-01-01 2024-12-31 03995362 frs-core:FurnitureFittings 2023-12-31 03995362 frs-core:ShareCapital 2024-12-31 03995362 frs-core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 03995362 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 03995362 frs-countries:UnitedKingdom 2024-01-01 2024-12-31 03995362 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 03995362 frs-bus:FullAccounts 2024-01-01 2024-12-31 03995362 frs-bus:FRS102 2024-01-01 2024-12-31 03995362 frs-bus:Audited 2024-01-01 2024-12-31 03995362 frs-bus:Medium-sizedCompaniesRegimeForAccounts 2024-01-01 2024-12-31 03995362 frs-bus:SmallCompaniesRegimeForDirectorsReport 2024-01-01 2024-12-31 03995362 frs-bus:OrdinaryShareClass1 2024-01-01 2024-12-31 03995362 frs-bus:OrdinaryShareClass1 2024-12-31 03995362 1 2024-01-01 2024-12-31 03995362 frs-core:DeferredTaxation 2024-01-01 2024-12-31 03995362 frs-core:DeferredTaxation 2023-12-31 03995362 frs-core:DeferredTaxation 2024-12-31 03995362 frs-bus:Director1 2024-01-01 2024-12-31 03995362 frs-bus:CompanySecretary1 2024-01-01 2024-12-31 03995362 1 2024-01-01 2024-12-31 03995362 frs-countries:EnglandWales 2024-01-01 2024-12-31 03995362 frs-countries:EnglandWales 2024-01-01 2024-12-31 03995362 2022-12-31 03995362 2023-12-31 03995362 2023-01-01 2023-12-31 03995362 frs-core:CurrentFinancialInstruments 2023-12-31 03995362 frs-core:ShareCapital 2022-12-31 03995362 frs-core:ShareCapital 2023-12-31 03995362 frs-core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 03995362 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2022-12-31 03995362 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 03995362 frs-countries:UnitedKingdom 2023-01-01 2023-12-31 03995362 frs-bus:OrdinaryShareClass1 2023-01-01 2023-12-31 03995362 1 2023-01-01 2023-12-31
Registered number: 03995362
D.M.H. Pharm Ltd
Director's Report and
Financial Statements
For The Year Ended 31 December 2024
Contents
Page
Director's Report 1—2
Independent Auditor's Report 3—6
Profit and Loss Account 7
Statement of Comprehensive Income 8
Balance Sheet 9
Statement of Changes in Equity 10
Notes to the Financial Statements 11—18
Page 1
Director's Report
The director presents his report and the financial statements for the year ended 31 December 2024.
Principal Activity
The company's principal activity continues to be that of retailing, and dispensing of pharmaceutical products and
related products.
Directors
The director who held office during the year were as follows:
Mr Amarbir Johal
Statement of Director's Responsibilities
The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing the financial statements the director is required to: 
  • select suitable accounting policies and then apply them consistently;
  • make judgments and accounting estimates that are reasonable and prudent;
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Statement of Disclosure of Information to Auditors
In the case of each director in office at the date the Director's Report is approved: 
  • so far as the director is aware, there is no relevant audit information of which the company's auditors are unaware; and
  • they have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information.
Independent Auditors
The auditors, De Montfort Advisory Limited, have indicated their willingness to continue in office and a resolution concerning their re-appointment will be proposed at the Annual General Meeting.
Page 1
Page 2
This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.
On behalf of the board
Mr Amarbir Johal
Director
22 September 2025
Page 2
Page 3
Independent Auditor's Report
Opinion
We have audited the financial statements of D.M.H. Pharm Ltd for the year ended 31 December 2024 which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes of Equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
In our opinion the financial statements:
  • give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit/(loss) for the year then ended;
  • have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
  • have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions Relating to Going Concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the entity's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The director is responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Page 3
Page 4
Opinions on Other Matters Prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
  • the information given in the Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
  • the Director's Report have been prepared in accordance with applicable legal requirements.
Matters on Which We Are Required to Report by Exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Director's Report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
  • adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
  • the financial statements are not in agreement with the accounting records or returns; or
  • certain disclosures of director's remuneration specified by law are not made; or
  • we have not received all the information and explanations we require for our audit.
Responsibilities of Directors
As explained more fully in the Director's Responsibilities Statement set out on page 1—2, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: 
...CONTINUED
Page 4
Page 5
Auditor's Responsibilities for the Audit of the Financial Statements - continued
  • the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
  • we identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial and sector experience, and through discussion with the directors and other management (as required by auditing standards), and discussed with the directors and other management the policies and procedures regarding compliance with laws and regulations.
  • we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including health and safety; General Data Protection Regulation (GDPR); fraud; bribery and corruption, employment law and The General Pharmaceutical (GPHc). Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the directors and other management and inspection of regulatory and legal correspondence, if any. The identified actual or suspected non-compliance was not sufficiently significant to our audit to result in our response being identified as a key audit matter.
  • we considered the legal and regulatory frameworks directly applicable to the financial statements reporting framework (FRS 102 and the Companies Act 2006) and the relevant tax compliance regulations in the UK.
  • we considered the nature of the industry, the control environment and business performance, including the key drivers for management’s remuneration;
  • we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and
  • identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.
  • we considered the procedures and controls that the company has established to address risks identified, or that otherwise prevent, deter and detect fraud; and how senior management monitors those programmes and controls.
We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
  • making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
  • considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.
Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Where the risk was considered to be higher, we performed audit procedures to address each identified fraud risk. These procedures included: testing manual journals; reviewing the financial statement disclosures and testing to supporting documentation; performing analytical procedures; and enquiring of management, and were designed to provide reasonable assurance that the financial statements were free from fraud or error.
Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. We are not responsible for preventing non-compliance and cannot be expected to detect noncompliance with all laws and regulations.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Page 5
Page 6
Use Of Our Report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters that we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Sandip Kumar (Senior Statutory Auditor)
for and on behalf of De Montfort Advisory Limited , Statutory Auditor
22 September 2025
De Montfort Advisory Limited
32 De Montfort Street
Leicester
Leicestershire
LE1 7GD
Page 6
Page 7
Profit and Loss Account
2024 2023
Notes £ £
TURNOVER 3 974,761 972,153
Cost of sales (668,237 ) (713,273 )
GROSS PROFIT 306,524 258,880
Administrative expenses (227,526 ) (197,872 )
OPERATING PROFIT 78,998 61,008
Interest payable and similar charges 7 (2,660 ) (4,974 )
PROFIT BEFORE TAXATION 76,338 56,034
Tax on Profit 8 (19,085 ) (13,915 )
PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR 57,253 42,119
The notes on pages 11 to 18 form part of these financial statements.
Page 7
Page 8
Statement of Comprehensive Income
2024 2023
£ £
PROFIT FOR THE FINANCIAL YEAR 57,253 42,119
OTHER COMPREHENSIVE INCOME FOR THE YEAR - -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 57,253 42,119
Page 8
Page 9
Balance Sheet
Registered number: 03995362
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 9 8,246 10,308
8,246 10,308
CURRENT ASSETS
Stocks 10 38,666 67,007
Debtors 11 218,747 222,010
Cash at bank and in hand 77,390 51,197
334,803 340,214
Creditors: Amounts Falling Due Within One Year 12 (196,202 ) (210,413 )
NET CURRENT ASSETS (LIABILITIES) 138,601 129,801
TOTAL ASSETS LESS CURRENT LIABILITIES 146,847 140,109
PROVISIONS FOR LIABILITIES
Deferred Taxation 13 (2,062 ) (2,577 )
NET ASSETS 144,785 137,532
CAPITAL AND RESERVES
Called up share capital 15 1,200 1,200
Profit and Loss Account 143,585 136,332
SHAREHOLDERS' FUNDS 144,785 137,532
On behalf of the board
Mr Amarbir Johal
Director
22 September 2025
The notes on pages 11 to 18 form part of these financial statements.
Page 9
Page 10
Statement of Changes in Equity
Share Capital Profit and Loss Account Total
£ £ £
As at 1 January 2023 1,200 94,213 95,413
Profit for the year and total comprehensive income - 42,119 42,119
As at 31 December 2023 and 1 January 2024 1,200 136,332 137,532
Profit for the year and total comprehensive income - 57,253 57,253
Dividends paid - (50,000) (50,000)
As at 31 December 2024 1,200 143,585 144,785
Page 10
Page 11
Notes to the Financial Statements
1. General Information
D.M.H. Pharm Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 03995362 . The registered office is 32 De Montfort Street , Leicester, Leicestershire, LE1 7GD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Significant judgements and estimations
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
2.4. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 20% on reducing balance
Page 11
Page 12
2.6. Investment Properties
All investment properties are carried at fair value determined annually and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided for. Changes in fair value are recognised in the profit and loss account.
2.7. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred.
2.8. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.
Cost is determined using the first-in, first-out method. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Work in progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
At the end of each reporting period stocks are assessed for impairment. If an item of stock is impaired, the identified stock is reduced to its selling price less costs to complete and sell and an impairment charge is recognised in the profit and loss account. Where a reversal of the impairment is required the impairment charge is reversed, up to the original impairment loss, and is recognised as a credit in the profit and loss account.
2.9. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.10. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Page 12
Page 13
2.11. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.12. Provisions and Contingencies
Provisions
Provisions are recognised when the company has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount of the obligation can be estimated reliably.
Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. A provision is recognised even if the likelihood of an outflow with respect to any one item included in the same class of obligations may be small.
Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as a finance cost.
Contingencies
Contingent liabilities are not recognised. Contingent liabilities arise as a result of past events when (i) it is not probable that there will be an outflow of resources or that the amount cannot be reliably measured at the reporting date or (ii) when the existence will be confirmed by the occurrence or non-occurrence of uncertain future events not wholly within the company’s control. Contingent liabilities are disclosed in the financial statements unless the probability of an outflow of resources is remote.
Contingent assets are not recognised. Contingent assets are disclosed in the financial statements when an inflow of economic benefits is probable.
Page 13
Page 14
2.13. Employee Benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock of fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
2.14. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.15. Government Grant
Government grants are recognised in the profit and loss account in an appropriate manner that matches them with the expenditure towards which they are intended to contribute.
Grants for immediate financial support or to cover costs already incurred are recognised immediately in the profit and loss account. Grants towards general activities of the entity over a specific period are recognised in the profit and loss account over that period.
Grants towards fixed assets are recognised over the expected useful lives of the related assets and are treated as deferred income and released to the profit and loss account over the useful life of the asset concerned.
All grants in the profit and loss account are recognised when all conditions for receipt have been complied with.
3. Turnover
Analysis of turnover by geographical market is as follows:
2024 2023
£ £
United Kingdom 974,761 972,153
974,761 972,153
4. Auditor's Remuneration
Remuneration received by the company's auditors and their associates during the year was as follows:
2024 2023
£ £
Audit Services
Audit of the company's financial statements 2,540 2,950
Page 14
Page 15
5. Staff Costs
Staff costs, including directors' remuneration, were as follows:
2024 2023
£ £
Wages and salaries 88,842 80,855
Social security costs 6,446 5,056
Other pension costs 1,657 618
96,945 86,529
6. Average Number of Employees
Average number of employees, including directors, during the year was: 5 (2023: 5)
5 5
7. Interest Payable and Similar Charges
2024 2023
£ £
Bank loans and overdrafts 1,818 846
Late payment tax charges 842 4,128
2,660 4,974
8. Tax on Profit
The tax charge on the profit for the year was as follows:
Tax Rate 2024 2023
2024 2023 £ £
Current tax
UK Corporation Tax 25.0% 25.0% 19,600 13,786
Deferred Tax
Deferred taxation (515 ) 129
Total tax charge for the period 19,085 13,915
The actual charge for the year can be reconciled to the expected charge for the year based on the profit and the standard rate of corporation tax as follows:
2024 2023
£ £
Profit before tax 76,338 56,034
Tax on profit at 25% (UK standard rate) 18,570 13,271
Goodwill/depreciation not allowed for tax 515 644
Total tax charge for the period 19,085 13,915
Page 15
Page 16
9. Tangible Assets
Fixtures & Fittings
£
Cost
As at 1 January 2024 37,151
As at 31 December 2024 37,151
Depreciation
As at 1 January 2024 26,843
Provided during the period 2,062
As at 31 December 2024 28,905
Net Book Value
As at 31 December 2024 8,246
As at 1 January 2024 10,308
10. Stocks
2024 2023
£ £
Finished goods 38,666 67,007
11. Debtors
2024 2023
£ £
Due within one year
Trade debtors 72,641 73,956
Amounts owed by group undertakings 136,324 136,324
Other debtors 9,782 11,730
218,747 222,010
12. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 138,545 163,082
Other creditors 350 147
Corporation tax 40,488 38,047
Taxation and social security 205 691
Accruals and deferred income 16,614 8,446
196,202 210,413
Page 16
Page 17
13. Deferred Taxation
The provision for deferred tax is made up as follows:
2024 2023
£ £
Other timing differences 2,062 2,577
14. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 January 2024 2,577 2,577
Deferred taxation (515 ) (515 )
Balance at 31 December 2024 2,062 2,062
15. Share Capital
2024 2023
Allotted, called up and fully paid £ £
1,200 Ordinary Shares of £ 1.00 each 1,200 1,200
16. Pension Commitments
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund.
During the year the charge to the profit and loss account in respect of defined contribution schemes was £1,657 (2023: £0).
At the balance sheet date contributions of £NIL were due to the fund and are included in creditors.
17. Related Party Disclosures
Amount owed by Saffron Apothecaries (Leicester) Limited - £136,324 (2023 - £136,324)
Saffron Apothecaries (Leicester) LimitedParent CompanyDividends paid - £50,000 (2023 - £nil)

Saffron Apothecaries (Leicester) Limited

Parent Company

Dividends paid - £50,000 (2023 - £nil)

Page 17
Page 18
18. Controlling Parties
The company's immediate parent undertaking is Saffron Apothecaries (Leicester) Limited .
The ultimate parent undertaking is Chase Pharmacy Limited (incorporated in England & Wales). Its registered office is 16 Central Street, Countesthorpe, Leicester, LE8 5QJ .
Copies of the group accounts may be obtained from the company's registered office.
The company's ultimate controlling party is Mr A S Johal and Mrs B K Johal by virtue of their interest in the share capital of the company.
Page 18